SOYDAL, Ç. Et Al. 2017. Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44 .

SOYDAL, Ç., ÖZKAN, E., Nak, D., ELHAN, A. H., Kucuk, N., & KIR, K. M., (2017). Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44.

SOYDAL, ÇİĞDEM Et Al. "Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44, 2017

SOYDAL, ÇİĞDEM Et Al. "Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44, 2017

SOYDAL, Ç. Et Al. (2017) . "Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44.

@article{article, author={ÇİĞDEM SOYDAL Et Al. }, title={Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma}, journal={EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}, year=2017}